Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Receives $60.00 Consensus PT from Analysts
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have given a buy rating […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the twenty brokerages that are covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, thirteen have given a buy rating […]
